189 related articles for article (PubMed ID: 12040283)
1. Prognostic factors and treatment modalities in uterine sarcoma.
El Husseiny G; Al Bareedy N; Mourad WA; Mohamed G; Shoukri M; Subhi J; Ezzat A
Am J Clin Oncol; 2002 Jun; 25(3):256-60. PubMed ID: 12040283
[TBL] [Abstract][Full Text] [Related]
2. Uterine sarcoma-current management and experience from a regional cancer centre in North India.
Biswas A; Patel F; Kumar P; Srinivasan R; Bera A; Sharma SC; Rajwanshi A
Arch Gynecol Obstet; 2013 Oct; 288(4):873-82. PubMed ID: 23580012
[TBL] [Abstract][Full Text] [Related]
3. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
[TBL] [Abstract][Full Text] [Related]
4. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
Feng W; Hua K; Malpica A; Zhou X; Baak JP
Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438
[TBL] [Abstract][Full Text] [Related]
5. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
[TBL] [Abstract][Full Text] [Related]
6. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic characteristics and prognosis factors of uterine sarcomas in central Tunisia].
Khlifi A; Fathallah K; Zbidi C; Hidar S; Bibi M; Khairi H
Bull Cancer; 2014; 101(7-8):669-80. PubMed ID: 25091649
[TBL] [Abstract][Full Text] [Related]
8. The management of patients with uterine sarcoma: a debated clinical challenge.
Gadducci A; Cosio S; Romanini A; Genazzani AR
Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
[TBL] [Abstract][Full Text] [Related]
9. [Uterine sarcomas: clinical and therapeutic aspects (10 cases)].
Hassini A; Khemiri B; Sfar E; Chelly D; Chennoufi MB; Chelly H
J Gynecol Obstet Biol Reprod (Paris); 2006 Jun; 35(4):348-55. PubMed ID: 16940904
[TBL] [Abstract][Full Text] [Related]
10. Endometrial stromal sarcoma of the uterus.
Meden H; Meyer-Rath D; Schauer A; Kuhn W
Anticancer Drugs; 1991 Feb; 2(1):35-7. PubMed ID: 1958850
[TBL] [Abstract][Full Text] [Related]
11. Uterine sarcoma. Clinico-pathological characteristics and outcome.
Sait HK; Anfinan NM; El Sayed ME; Alkhayyat SS; Ghanem AT; Abayazid RM; Sait KH
Saudi Med J; 2014 Oct; 35(10):1215-22. PubMed ID: 25316466
[TBL] [Abstract][Full Text] [Related]
12. [Uterine sarcoma in Tunisia: retrospective study about 14 cases].
Bouzid N; Kanoun Belajouza S; Boussen H; Bouaouina N
Gynecol Obstet Fertil; 2014 Dec; 42(12):838-43. PubMed ID: 25155830
[TBL] [Abstract][Full Text] [Related]
13. Uterine sarcomas: a review of the Edinburgh experience from 1974 to 1992.
Tinkler SD; Cowie VJ
Br J Radiol; 1993 Nov; 66(791):998-1001. PubMed ID: 8281393
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1277-87. PubMed ID: 18506484
[TBL] [Abstract][Full Text] [Related]
15. Treatment of early uterine sarcomas: disentangling adjuvant modalities.
Zagouri F; Dimopoulos AM; Fotiou S; Kouloulias V; Papadimitriou CA
World J Surg Oncol; 2009 Apr; 7():38. PubMed ID: 19356236
[TBL] [Abstract][Full Text] [Related]
16. Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors.
Katz L; Merino MJ; Sakamoto H; Schwartz PE
Gynecol Oncol; 1987 Jan; 26(1):87-97. PubMed ID: 3792939
[TBL] [Abstract][Full Text] [Related]
17. Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998.
Livi L; Andreopoulou E; Shah N; Paiar F; Blake P; Judson I; Harmer C
Clin Oncol (R Coll Radiol); 2004 Jun; 16(4):261-8. PubMed ID: 15214650
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of uterine carcinosarcoma: results of 94 patients.
Gokce ZK; Turan T; Karalok A; Tasci T; Ureyen I; Ozkaya E; Kose MF; Tulunay G
Int J Gynecol Cancer; 2015 Feb; 25(2):279-87. PubMed ID: 25611900
[TBL] [Abstract][Full Text] [Related]
19. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant management of operated uterine sarcomas: A single institution experience.
Cordoba A; Prades J; Basson L; Robin YM; Taïeb S; Narducci F; Hudry D; Bresson L; Chevalier A; Le Tinier F; Mirabel X; Lartigau É; Penel N; Leblanc É
Cancer Radiother; 2019 Sep; 23(5):401-407. PubMed ID: 31351809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]